Bristol-Myers Squibb Company
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2007 | $3.15B | $2.31B | $843.0M | $133.0M |
| FY2008 | $3.71B | $2.77B | $941.0M | $181.0M |
| FY2009 | $4.07B | $3.34B | $730.0M | $183.0M |
| FY2010 | $4.49B | $4.07B | $424.0M | $193.0M |
| FY2011 | $4.84B | $4.47B | $367.0M | $161.0M |
| FY2012 | $6.94B | $6.39B | $548.0M | $154.0M |
| FY2013 | $3.55B | $3.01B | $537.0M | $191.0M |
| FY2014 | $3.15B | $2.62B | $526.0M | $213.0M |
| FY2015 | $2.11B | $1.29B | $820.0M | $235.0M |
| FY2016 | $3.06B | $1.84B | $1.22B | $205.0M |
| FY2017 | $5.28B | $4.22B | $1.06B | $199.0M |
| FY2018 | $7.07B | $6.12B | $951.0M | $221.0M |
| FY2019 | $8.21B | $7.37B | $836.0M | $441.0M |
| FY2020 | $14.05B | $13.30B | $753.0M | $779.0M |
| FY2021 | $16.21B | $15.23B | $973.0M | $583.0M |
| FY2022 | $13.07B | $11.95B | $1.12B | $457.0M |
| FY2023 | $13.86B | $12.65B | $1.21B | $518.0M |
| FY2024 | $15.19B | $13.94B | $1.25B | $507.0M |
| FY2025 | $14.16B | $12.85B | $1.31B | $553.0M |